Where it is registered
Each register with its number of medicines and a few of them.
Spain
AEMPS · 3 medicines
- BILINA 0,5 mg/ml COLIRIO EN SUSPENSIÓN0,54 mg · colirio en suspensión · Esteve Pharmaceuticals S.A.
- REACTINE LEVOCABASTINA 0,5mg/ml COLIRIO EN SUSPENSION0,54 mg · colirio en suspensión · Jntl Consumer Health (Spain) S.L.
- BILINA 0,5 mg/ml SUSPENSIÓN PARA PULVERIZACIÓN NASAL0,5 mg · solucion para pulverizacion nasal · Esteve Pharmaceuticals S.A.
Canada
Health Canada · 2 medicines · Historical list
Italy
AIFA · 2 medicines
Netherlands
CBG-MEB · 2 medicines
All medicines with Levocabastine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
16 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Livostin | United States | 0.05% BASE | suspension/drops | Not marketed | Novartis |
| REACTINE LEVOCABASTINA 0,5mg/ml COLIRIO EN SUSPENSION | Spain | 0,54 mg | colirio en suspensión | Marketed | Jntl Consumer Health (Spain) S.L. |
| Levoreact | Italy | Spray nasale, sospensione | Authorised | Kenvue Italia S.P.A. | |
| Levoreact Oftalmico | Italy | Collirio, sospensione | Authorised | Kenvue Italia S.P.A. | |
| Livocab 0,5 mg/ml neusspray, suspensie | Netherlands | Neusspray, suspensie | Authorised | Kenvue Netherlands B.V. | |
| Livocab 0,5 mg/ml oogdruppels, suspensie | Netherlands | Oogdruppels, suspensie | Authorised | Kenvue Netherlands B.V. | |
| BILINA 0,5 mg/ml COLIRIO EN SUSPENSIÓN | Spain | 0,54 mg | colirio en suspensión | Marketed | Esteve Pharmaceuticals S.A. |
| Livostin | New Zealand | Eye drops 0.5 mg per ml | Funded | ||
| Any | New Zealand | Eye drops 0.05% | Funded | ||
| Livostin Eye Drops 0.5MG-ML | Saudi Arabia | Authorised | Janssen Pharmaceutica N.V. | ||
| Livostin Nasal Spray 0.5MG-ML | Saudi Arabia | Authorised | Janssen Pharmaceutica N.V. | ||
| Livostin Eye Drops | Canada | 0.5 MG / ML | Drops, Suspension | Cancelled | Novartis Pharmaceuticals Canada INC |
| BILINA 0,5 mg/ml SUSPENSIÓN PARA PULVERIZACIÓN NASAL | Spain | 0,5 mg | solucion para pulverizacion nasal | Withdrawn | Esteve Pharmaceuticals S.A. |
| Livostin Sus Nas 0.5MG/ML | Canada | 0.05 MG / ACT | Spray, Suspension | Cancelled | Janssen INC |
| Livostin Nasal Spray 50UG/Dose | Taiwan | 鼻用氣化噴霧劑 | Cancelled | 嬌生股份有限公司 | |
| Livostin Ophthalmic Suspension | Taiwan | 點眼懸液劑 | Cancelled | 嬌生股份有限公司 |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
- Esteve Pharmaceuticals S.A.2 medicines
- 嬌生股份有限公司2 medicines
- Kenvue Netherlands B.V.2 medicines
- Kenvue Italia S.P.A.2 medicines
- Janssen Pharmaceutica N.V.2 medicines
- Janssen Inc1 medicine
- Jntl Consumer Health (Spain) S.L.1 medicine
- Novartis Pharmaceuticals Canada Inc1 medicine
- Novartis Pharmaceuticals Corporation
Names in the registers
How the registers write it, in their own languages.
- Levocabastina
- Levocabastinehydrochloride
Sources
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, CBG-MEB, FDA, Health Canada, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 8
- Medicines
- 16
- Companies
- 9